コンテンツへスキップ
Merck
  • An investigation into the drug release from ibuprofen matrix tablets with ethylcellulose and some poly-acrylate polymers.

An investigation into the drug release from ibuprofen matrix tablets with ethylcellulose and some poly-acrylate polymers.

Pakistan journal of pharmaceutical sciences (2014-05-09)
Hosseinali Tabandeh, Seyed Alireza Mortazavi
要旨

This study was performed to achieve sustained-release Ibuprofen matrix tablets with a zero-order release kinetic while most of the previous formulations have shown Higuchi release kinetic. Considering the results from previous studies, ethyl cellulose, Carbopol 934P, Carbopol 974P, and Pemulen TR-1 were used at different amounts for preparation of the tablets by direct compression. The release profiles were studied in a two-stage release test using non-linear regression analysis. Carbopols 934P and 974P could not sustain the release adequately while Pemulen TR-1 had too strong sustaining effect. Therefore, combination formulations were considered and studied. The release profiles of ethyl cellulose formulation and the combination formulation consisting Carbopol 934P and Pemulen TR-1 best fitted in Higuchi model, although the zero-order model was not completely rejected. However, the kinetic model of release from the combination formulation consisting Carbopol 974P and Pemulen TR-1 changed to zero-order indicating the most constant release rate among formulations. This was speculated to be due to some erosion of the gel, as well as some interaction of the hydrophobic chain of Pemulen TR-1 with Ibuprofen. Therefore, this formulation is suggested for directly compressed sustained-release matrix tablets of Ibuprofen with a more constant release rate.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
セルロース, microcrystalline, powder, 20 μm
Sigma-Aldrich
イブプロフェン, ≥98% (GC)
Sigma-Aldrich
セルロース, microcrystalline, powder
Sigma-Aldrich
セルロース, fibers, (medium)
Sigma-Aldrich
エチルセルロース, 48.0-49.5% (w/w) ethoxyl basis
Sigma-Aldrich
Sigmacell セルロース, Type 20, 20 μm
Sigma-Aldrich
エチルセルロース, 48.0-49.5% (w/w) ethoxyl basis
Sigma-Aldrich
α-セルロース, powder
USP
イブプロフェン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
(S)-(+)-イブプロフェン, ReagentPlus®, 99%
Sigma-Aldrich
セルロース, colloidal, microcrystalline
Supelco
イブプロフェン
Sigma-Aldrich
エチルセルロース, viscosity 100 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl
Sigma-Aldrich
エチルセルロース, viscosity 46 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl
Sigma-Aldrich
エチルセルロース, viscosity 4 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl
Sigma-Aldrich
Sigmacellセルロース, Type 101, Highly purified, fibers
Sigma-Aldrich
Sigmacell セルロース, Type 50, 50 μm
Sigma-Aldrich
エチルセルロース, viscosity 22 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl
Sigma-Aldrich
エチルセルロース, viscosity 10 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl
Sigma-Aldrich
α-セルロース, BioReagent, suitable for insect cell culture
Sigma-Aldrich
エチルセルロース, viscosity 300 cP, 5 % in toluene/ethanol 80:20(lit.), extent of labeling: 48% ethoxyl
Supelco
イブプロフェン 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
イブプロフェン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Avicel® PH-101, ~50 μm particle size
Supelco
イブプロフェン ナトリウム塩, ≥98% (GC)
USP
エチルセルロース, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Avicel® PH-101, tested according to Ph. Eur.
Supelco
セルロース, powder, for column chromatography
Sigma-Aldrich
エチルセルロース, CP, viscosity 45 cP 
イブプロフェン, European Pharmacopoeia (EP) Reference Standard